| The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis Y Zhao, X Ge, J He, Y Cheng, Z Wang, J Wang, L Sun World journal of surgical oncology 17, 1-11, 2019 | 96 | 2019 |
| A circulating extracellular vesicles‐based novel screening tool for colorectal cancer revealed by shotgun and data‐independent acquisition mass spectrometry X Zheng, K Xu, B Zhou, T Chen, Y Huang, Q Li, F Wen, W Ge, J Wang, ... Journal of extracellular vesicles 9 (1), 1750202, 2020 | 95 | 2020 |
| SP1-induced lncRNA TINCR overexpression contributes to colorectal cancer progression by sponging miR-7-5p S Yu, D Wang, Y Shao, T Zhang, H Xie, X Jiang, Q Deng, Y Jiao, J Yang, ... Aging (Albany NY) 11 (5), 1389, 2019 | 62 | 2019 |
| Laparoscopic surgery for the curative treatment of rectal cancer: results of a Chinese three-center case–control study KF Ding, R Chen, JL Zhang, J Li, YQ Xu, L Lv, XC Wang, LF Sun, ... Surgical endoscopy 23, 854-861, 2009 | 51 | 2009 |
| Prognostic value and clinicopathological roles of phenotypes of tumour-associated macrophages in colorectal cancer Y Zhao, X Ge, X Xu, S Yu, J Wang, L Sun Journal of cancer research and clinical oncology 145, 3005-3019, 2019 | 50 | 2019 |
| A giant hemolymphangioma of the pancreas in a 20-year-old girl: a report of one case and review of the literature LF Sun, HL Ye, QY Zhou, KF Ding, PL Qiu, YC Deng, SZ Zhang, S Zheng World Journal of Surgical Oncology 7, 1-3, 2009 | 48 | 2009 |
| Laparoscopic surgery contributes more to nutritional and immunologic recovery than fast-track care in colorectal cancer D Xu, J Li, Y Song, J Zhou, F Sun, J Wang, Y Duan, Y Hu, Y Liu, X Wang, ... World Journal of Surgical Oncology 13, 1-9, 2015 | 47 | 2015 |
| Small role with big impact: miRNAs as communicators in the cross-talk between cancer-associated fibroblasts and cancer cells Z Wang, Y Tan, W Yu, S Zheng, S Zhang, L Sun, K Ding International journal of biological sciences 13 (3), 339, 2017 | 41 | 2017 |
| MicroRNA regulation network in colorectal cancer metastasis JJ Zhou, S Zheng, LF Sun, L Zheng World journal of biological chemistry 5 (3), 301, 2014 | 41 | 2014 |
| Protein interaction analysis of ST14 domains and their point and deletion mutants W Ge, H Hu, K Ding, L Sun, S Zheng Journal of Biological Chemistry 281 (11), 7406-7412, 2006 | 28 | 2006 |
| Adenosquamous carcinoma of the uncinate process of the pancreas with synchronous gastrointestinal stromal tumor of the stomach: Case report and review of the literature JJ He, KF Ding, L Zheng, JH Xu, J Li, YL Wu, LF Sun, DE Zhou, S Zheng Oncology Letters 4 (6), 1191-1194, 2012 | 20 | 2012 |
| Effect of SNC19/ST14 gene overexpression on invasion of colorectal cancer cells KF Ding, LF Sun, WT Ge, HG Hu, SZ Zhang, S Zheng World journal of gastroenterology: WJG 11 (36), 5651, 2005 | 20 | 2005 |
| Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target Y Shao, K Xu, X Zheng, B Zhou, X Zhang, L Wang, Y Sun, D Li, T Chen, ... Cancer Communications 42 (2), 164-169, 2022 | 19 | 2022 |
| Sintilimab plus bevacizumab, oxaliplatin and capecitabine as first-line therapy in RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer: an open-label … X Fang, N Zhu, C Zhong, L Wang, J Li, S Weng, H Hu, C Dong, D Li, ... EClinicalMedicine 62, 2023 | 17 | 2023 |
| Integrin αvβ6 contributes to the development of intestinal fibrosis via the FAK/AKT signaling pathway H Xie, Y Jiao, X Zhou, X Liao, J Chen, H Chen, L Chen, S Yu, Q Deng, ... Experimental Cell Research 411 (2), 113003, 2022 | 17 | 2022 |
| Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line therapy Y Liu, Q Xiao, J He, H Hu, J Du, Y Zhu, J Chen, Z Liu, J Wang, L Sun, ... BMC medicine 20 (1), 155, 2022 | 16 | 2022 |
| Extent of enhancement on multiphase contrast-enhanced CT images is a potential prognostic factor of stage I–III colon cancer Z Wang, Y Ye, Y Hu, S Han, L Sun, D Xu, K Ding European radiology 29, 1114-1123, 2019 | 16 | 2019 |
| A phase 2 trial of sintilimab (IBI 308) in combination with CAPEOX and bevacizumab (BBCAPX) as first-line treatment in patients with RAS-mutant, microsatellite stable … X Fang, C Zhong, N Zhu, S Weng, H Hu, J Wang, Q Xiao, J Wang, Y Song, ... Journal of Clinical Oncology 40 (16_suppl), 3563-3563, 2022 | 15 | 2022 |
| Cancer immunotherapies targeting tumor-associated regulatory T cells X Ge, Y Zhao, C Chen, J Wang, L Sun OncoTargets and therapy, 11033-11044, 2019 | 15 | 2019 |
| An efficient prognostic immune scoring system for colorectal cancer patients with peritoneal metastasis Y Zhao, C Chen, X Xu, X Ge, K Ding, S Zheng, J Wang, L Sun Oncoimmunology 10 (1), 1901464, 2021 | 13 | 2021 |
